fbpx

Medication lowered the risk for cardiovascular events among patients with rheumatoid arthritis

Researchers from the University of British Columbia in Vancouver reported a significantly reduced risk for cardiovascular events among patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) who are on hydroxychloroquine.

Medication lowered the risk for cardiovascular events among patients with rheumatoid arthritis
Scroll to top
Social media & sharing icons powered by UltimatelySocial
error

Enjoy this blog? Please spread the word :)